Cite
MLA Citation
Joseph Clark et al.. “Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2).” Journal for immunotherapy of cancer, vol. 3, no. 2, 2015, pp. 1–2. http://access.bl.uk/ark:/81055/vdc_100080441580.0x000036